Stock INAF PT INDOFARMA TBK
Add to a list
To use this feature you must be a member
Log inSign up

Company PT Indofarma Tbk

Equities

INAF

ID1000068406

Pharmaceuticals

End-of-day quote INDONESIA S.E.
Other stock markets
 06:00:00 2024-05-13 pm EDT 		5-day change 1st Jan Change
191 IDR +8.52% Intraday chart for PT Indofarma Tbk +28.19% -67.07%
2023 PT Indofarma Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
2023 PT Indofarma Tbk Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Business Summary

PT Indofarma Tbk is an Indonesia-based company, which is engaged in the healthcare industry. The Company's business segment based on the products consists of the drug business segment and other medical equipment segment. The medical equipment segment consists of diagnostic and medical equipment. Its business segment based on geographical distribution area covers five regions consisting of Sumatra, Java, Kalimantan, Sulawesi and Bali, West Nusa Tenggara, and East Indonesia. Its products and services include generic drugs, over-the-counter and food, medical devices, non-medical devices and household health products. The Company carries out business activities to produce either alone or under cooperation for finished drug products, such as essential medicines, generic medicines with logos, generic medicines with trade names, traditional medicines, medical equipment, diagnostics, as well as food products, both related to health maintenance and improvement as well as health restoration.

Number of employees: 1,086

Sales per Business

IDR in Million2021Weight2022Weight Delta
Medical Devices and Others
51.4 %
802,101 27.6 % 587,957 51.4 % -26.70%
Medicine
48.6 %
2,099,886 72.4 % 556,152 48.6 % -73.52%

Sales per region

IDR in Million2021Weight2022Weight Delta
Indonesia
100.0 %
2,901,987 100.0 % 1,144,108 100.0 % -60.57%

Managers

Managers TitleAgeSince
Agus Heru Darjono CEO
 Chief Executive Officer - 23-01-29
Ariesta Krisnawan DFI
 Director of Finance/CFO 57 22-05-30
Hugo Koen Christanto CTO
 Chief Tech/Sci/R&D Officer - -
Joko Suparno CTO
 Chief Tech/Sci/R&D Officer - -
Warjoko Sumedi CMP
 Compliance Officer 53 06-12-31
Benny Emirald Hutasuhut AUD
 Comptroller/Controller/Auditor - -
Kamelia Faisal SAM
 Sales & Marketing 54 22-05-30
Hilda Yani SEC
 Corporate Secretary 48 -
Sigit Prakosa AUD
 Comptroller/Controller/Auditor - -
Jejen Nugraha PRN
 Corporate Officer/Principal 44 21-05-20

Members of the board

Members of the board TitleAgeSince
Teddy Wibisana BRD
 Director/Board Member 57 15-04-07
Didi Agus Mintadi BRD
 Director/Board Member 63 20-07-28
Laksono Trisnantoro CHM
 Chairman 62 21-05-19
Achmad Ghufron Sirodj BRD
 Director/Board Member 40 22-05-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,099,267,500 599,267,500 ( 19.34 %) 0 19.34 %

Shareholders

NameEquities%Valuation
PT Bio Farma
80.66 %
2,499,999,999 80.66 % 20 M Rp
Government of Indonesia
7.342 %
227,533,850 7.342 % 2 M Rp

Company contact information

PT Indofarma Tbk

Jalan Indofarma No. 1 Cikarang Barat

17530, Bekasi

+

http://indofarma.id/en
address PT Indofarma Tbk(INAF)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
PT INDOFARMA TBK Stock PT Indofarma Tbk
-67.07% 36.78M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.20% 588B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.23% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.29% 326B
ABBVIE INC. Stock AbbVie Inc.
+4.81% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.45% 239B
NOVARTIS AG Stock Novartis AG
+10.36% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-7.24% 200B
AMGEN INC. Stock Amgen Inc.
+8.88% 167B
PFIZER, INC. Stock Pfizer, Inc.
-0.57% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. INAF Stock
  4. Company PT Indofarma Tbk
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW